Evidence map›Paper›PMID 41715205›Full record

ArticleGenome biology2026

Network-based framework for studying etiology and phenotypic diversity in primary ciliopathies.

Ellen M Aarts, Diederik S Laman Trip, Ruxandra Neatu, Charlotte G Martin, Beth Riley, Alison Kraus, Abigail Green, Mohamed H Al-Hamed, Rachel E Armstrong, John A Sayer and 2 more

Abstract read
In one paragraph

Article in Genome biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ellen M AartsInstitute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.
Diederik S Laman TripInstitute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.
Ruxandra NeatuBioscience Institute, Newcastle University, Newcastle Upon Tyne, UK.
Charlotte G MartinBioscience Institute, Newcastle University, Newcastle Upon Tyne, UK.
Beth RileyBioscience Institute, Newcastle University, Newcastle Upon Tyne, UK.
Alison KrausYorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK.
Abigail GreenYorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK.
Mohamed H Al-HamedDepartment of Clinical Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, 11211, Saudi Arabia.
Rachel E ArmstrongBioscience Institute, Newcastle University, Newcastle Upon Tyne, UK.
John A SayerBioscience Institute, Newcastle University, Newcastle Upon Tyne, UK.
Ruxandra Bachmann-Gagescu *Institute of Medical Genetics, University of Zurich, Schlieren, Switzerland. ruxandra.bachmann@mls.uzh.ch.
Pedro Beltrao *Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland. pbeltrao@ethz.ch.

Funding

Personalized Health and Related Technologies 2022-37Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 310030_220012
6 · The paper itself

Abstract

backgroundRecent advances in sequencing technologies have increasingly enabled the identification of genetic causes for human monogenic diseases. However, systematic understanding remains limited due to the rarity, genetic heterogeneity, and complex genotype–phenotype relationships of these diseases. Primary ciliopathies are a diverse group of rare disorders caused by variants in genes associated with the cilium, a cellular organelle involved in signaling during development and cell homeostasis. These genetic variants result in a wide spectrum of clinical phenotypes involving the brain, eye, kidney, and skeleton. It remains unclear to what extent this phenotypic diversity can be attributed to the disease-causing genes and their specific roles in ciliary function.

resultsHere, we systematically compared human primary ciliopathies with each other and with mouse phenotypes by propagating known disease genes through a network of protein interactions. Network propagation improved the clustering of primary ciliopathies with shared clinical phenotypes and facilitated the identification of mouse phenotypes closely related to primary ciliopathies, due to shared groups of proteins in the interaction network. By leveraging this phenotype-specific approach, we prioritized candidate genes for specific ciliopathies and identified likely pathogenic variants in CEP43, a previously unrecognized ciliopathy gene, in three previously unsolved cases.

conclusionsThis study demonstrates that network propagation enhances the genetic and phenotypic understanding of primary ciliopathies, aiding in the prioritization of candidate genes and providing a framework for unraveling shared underlying mechanisms for other rare genetic diseases.

Indexed as

CiliopathiesAnimalsCiliaGenetic Association StudiesHumansMicePhenotypeProtein Interaction Maps

Identifiers

PMID41715205
PMCPMC13020049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.